Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Overnight switch from pramipexole or ropinirole to rotigotine patch in idiopathic restless legs syndrome
2007-006558-24Phase 3Terminated
- Sponsor
- Schwarz Pharma
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of rotigotine in restless legs syndrome (RLS), sponsored by Schwarz Pharma. Primary endpoints: Practicability of overnight switch, Tolerability of rotigotine after overnight switch and 1 more. Started Feb 2008; status: terminated.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2007-006558-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006558-24.